Clinical Genomic Analyses Demonstrate t(11;14) Multiple Myeloma Retains B-Cell Biology and Distinct Mitochondrial Metabolism That Convey Increased Sensitivity to BCL-2 Inhibition By Venetoclax

威尼斯人 生物 多发性骨髓瘤 癌症研究 遗传学 分子生物学 免疫学 白血病 慢性淋巴细胞白血病
作者
David Sharon,Fengjiao Dunbar,Paul Jung,Xifeng Wang,Xiaotong Li,Christine Mantis,Orlando F. Bueno,Cyrille Touzeau,Philippe Moreau,Simon J. Harrison,Luciano J. Costa,Jonathan L. Kaufman,Nizar J. Bahlis,Shaji Kumar,Jeremy A. Ross,PK Epling-Burnette
出处
期刊:Blood [Elsevier BV]
卷期号:140 (Supplement 1): 4242-4244
标识
DOI:10.1182/blood-2022-160195
摘要

Introduction: Venetoclax (Ven) is a selective, potent, oral BCL-2 inhibitor under investigation as a targeted therapy for t(11;14)-positive relapsed/refractory multiple myeloma (RRMM). The molecular mechanisms underlying the increased sensitivity of t(11;14) MM to Ven have not been fully elucidated; however, remnants of B-cell biology and reduced cellular bioenergetics have been associated with sensitivity to Ven in MM. Transcriptomic analysis of 302 RRMM patient tumor cells before treatment with Ven-based regimens, an ex vivo B-cell differentiation model, and metabolic profiling of 7 MM cell lines were assessed to understand the unique biology that distinguishes t(11;14) in MM. Methods: CD138-enriched bone marrow mononuclear cells were collected at baseline from multiple Ven clinical trials (NCT02755597, NCT01794520, NCT03314181, NCT02899052). Biomarker analyses, including BCL2 gene expression by quantitative PCR, t(11;14) status by interphase fluorescence in situ hybridization (FISH), and transcriptomic analysis by RNA sequencing (RNA-seq), were performed by a central laboratory. Isolated healthy memory B-cells (MBCs) were progressively differentiated ex vivo into pre-plasmablast (Pre-PB), plasmablast (PB), and plasma cells (PC). MM cell lines were differentiated by treatment with all-trans retinoic acid (ATRA) for 3-days. Global metabolomic profiling was performed by liquid chromatography-mass spectrometry (LC-MS) in MM cell lines with or without ATRA-mediated differentiation. Gene set variation analysis (GSVA) was used to establish B-cell and mitochondrial (Mito) gene signatures. Results: Consistent with previous findings, t(11;14)-positive RRMM expressed significantly higher CCND1 (mean log2 FPKM: 3.8 vs −0.4, P<.0001) and BCL2 levels (mean 2-ΔCt: 1.3 vs 0.4, P<.0001) compared with t(11;14)-negative RRMM. Using a network-based enrichment map to interrogate differentially expressed genes, transcriptomes of t(11;14)-positive samples were enriched in several pathways, including cell cycle, metabolism and biosynthesis, and immune pathways. Significantly higher B-cell signature scores, but lower Mito signature scores were detected in t(11;14)-positive versus t(11;14)-negative RRMM patients (P<.0001; Figure). The ex vivo B-cell differentiation model confirmed that B-cell and Mito scores are differentiation-stage specific and significantly changed upon differentiation to plasma cells (P<.0001). In RRMM patients, there was an inverse correlation between the B-cell and Mito signature scores (R=−0.6, P<.0001). In vitro models were then used to further investigate the relationship between B-cell differentiation and Ven sensitivity. ATRA differentiated t(11;14)-positive MM cell lines, as indicated by lower expression of CD20 and increased expression of the plasma cell markers CD138 and CD38, significantly reduced BCL2 expression and increased basal rates of respiration in association with increased mitochondrial mass, which correlated with reduced Ven sensitivity. Differentially expressed metabolites were overrepresented in the purine biosynthetic pathway in t(11;14)-positive MM cell lines, which was corroborated by differential gene expression within this pathway in the ex vivo B-cell differentiation model and in t(11;14)-positive RRMM patients. Using thresholds that balance sensitivity and specificity of the B-cell and Mito signature scores associated with t(11;14)-positive RRMM, progression-free survival (PFS) outcomes in the BELLINI study were not superior to those demonstrated by t(11;14) or high BCL2 expression status alone (Table). Conclusions: Using an integrated approach of transcriptomic and metabolomic profiling, t(11;14) MM cells were confirmed to retain features of B-cell biology, including lower Mito metabolism that results in increased sensitivity to BCL-2 inhibition by Ven. Although these biological features are closely linked to t(11;14), B-cell gene or Mito gene signatures did not serve as better biomarkers for predicting efficacy to Ven compared with t(11;14) alone. Figure 1View largeDownload PPTFigure 1View largeDownload PPT Close modal
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
成就伟祺关注了科研通微信公众号
1秒前
能干的语芙完成签到 ,获得积分10
1秒前
无欲无求傻傻完成签到,获得积分10
1秒前
1秒前
1秒前
尊敬寒松完成签到 ,获得积分10
1秒前
糊涂的麦片完成签到,获得积分10
1秒前
2秒前
2秒前
3秒前
wanci应助wangdafa采纳,获得10
3秒前
竹子co完成签到,获得积分10
3秒前
steventj完成签到,获得积分10
3秒前
yz完成签到 ,获得积分10
4秒前
朴实山兰完成签到,获得积分10
5秒前
tkkdy发布了新的文献求助10
5秒前
蓁蓁发布了新的文献求助10
5秒前
醉熏的鑫发布了新的文献求助10
6秒前
独家双层汉堡完成签到,获得积分10
6秒前
Li完成签到,获得积分10
7秒前
xcx发布了新的文献求助10
7秒前
江小小发布了新的文献求助10
8秒前
8秒前
乐乐乐乐乐乐应助大橙子采纳,获得10
8秒前
伍六七完成签到,获得积分10
9秒前
shinen发布了新的文献求助10
9秒前
文艺的又亦完成签到,获得积分10
9秒前
小蘑菇应助妍儿采纳,获得10
10秒前
11秒前
义气天真完成签到,获得积分10
11秒前
满意易蓉发布了新的文献求助10
12秒前
12秒前
303完成签到 ,获得积分10
13秒前
海阔光明完成签到,获得积分10
13秒前
酷波er应助樾苒采纳,获得10
13秒前
Bingo完成签到,获得积分10
14秒前
hhhh完成签到 ,获得积分10
14秒前
小Q完成签到,获得积分10
15秒前
wangdafa发布了新的文献求助10
15秒前
wjq泉完成签到 ,获得积分20
16秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds第二卷 1200
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038657
求助须知:如何正确求助?哪些是违规求助? 3576306
关于积分的说明 11375198
捐赠科研通 3306108
什么是DOI,文献DOI怎么找? 1819379
邀请新用户注册赠送积分活动 892698
科研通“疑难数据库(出版商)”最低求助积分说明 815066